Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 395 of 6351
-
New combo therapy aims to boost lung cancer treatment
Disease control Recruiting nowMonocentric study composed by 2 steps : 1. First step is a phase I with the aim of establish the recommended dose of mirdametinib administration (2 or 4 mg twice a day for 7 or 14 days per cycle for the 4 first of carboplatin/pemetrexed/pembrolizumab treatment) 2. Second step is…
Phase 1/2 • Sponsor: Centre Georges Francois Leclerc • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New triple therapy aims to slow advanced lung cancer
Disease control Recruiting nowThis is a single center, phase Ib/II study combining an anti-PD-1 antibody and an anti-CTLA-4 antibody with IL-15. It is testing the hypothesis that the addition of nogapendekin alfa inbakicept to nivolumab and ipilimumab will augment the clinical activity of those two drugs.
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New antibody aims to keep myeloma at bay after transplant
Disease control Recruiting nowThis is a prospective, single-arm clinical study designed to evaluate the efficacy and safety of the BCMA/CD3 bispecific antibody (CM336) as maintenance therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New heart zapping device could free patients from irregular heartbeat
Disease control Recruiting nowThe goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely and effectively treat symptomatic, drug-refractory Paroxysmal atrial fibrillation (PAF) and Persistent atrial fibrillation (PersAF). The main question it aims to…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New combo therapy targets tough lung cancer
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of AK138D1 as monotherapy or in combination with ivonescimab in patients with advanced non-small cell lung cancer. Participants will receive study treatment with AK138D1 alone or in combination…
Phase 1/2 • Sponsor: Akeso • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New lozenge aims to ease radiation mouth sores for hours
Symptom relief Recruiting nowMost patients who receive radiation therapy for head and neck cancer develop painful sores in the mouth called oral mucositis. For many of them, these sores are severe and result in debilitating pain. The sores usually start in the third week of radiation and last aboutfive weeks…
Phase 3 • Sponsor: OncoZenge AB • Aim: Symptom relief
Last updated Sep 10, 2026 03:00 UTC
-
One-Time brain injection targets genetic form of Parkinson's
Disease control Not yet recruitingThis is a prospective, single-arm, single-dose clinical study designed to evaluate the safety, tolerability, efficacy, immunogenicity, pharmacodynamic (PD) and pharmacokinetic (PK) profiles of LY-N001 Injection in patients with moderate-to-advanced Parkinson's disease carrying GB…
Early phase 1 • Sponsor: Lingyi Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Warm liver transplants: could ditching the ice bath reduce organ damage?
Disease control Recruiting nowThe ARANMP-LT study is a multicenter, open-label, randomized, parallel-group, non-inferiority clinical trial designed to evaluate whether avoiding graft recooling after normothermic machine perfusion (NMP) improves early outcomes following liver transplantation. Although graft re…
Sponsor: The Mediterranean Institute for Transplantation and Advanced Specialized Therapies • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a scent of lavender and orange calm nerves before surgery?
Symptom relief Recruiting nowAromatherapy's Impact on Preoperative Anxiety, Postoperative Pain, and Patient Experience Introduction: Surgery often results in increased levels of anxiety and postoperative pain. Postoperative pain relief is typically treated with opioids. However, evidence shows that treatme…
Sponsor: Kaiser Permanente • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can a targeted scan outshine standard imaging for multiple myeloma?
Diagnosis Recruiting nowThe objective of the study is to construct a noninvasive approach CD38 targeted PET/CT to detect tumor lesions in patients with Multiple Myeloma and to compare with FDG PET/CT.
Sponsor: Guilin Medical University, China • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC
-
Could thousands of women skip hormone therapy after breast cancer?
Disease control Recruiting nowThe goal of this clinical trial is to determine whether a selected population of women with early-stage, low-risk breast cancer can avoid hormone therapy without increasing their risk of relapse. It will also evaluate the prognosis of these participants compared to participants w…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope: Alzheimer's trial targets tau tangles to slow memory loss
Disease control Recruiting nowThe goal of the Alzheimer's Tau Platform (ATP) is to evaluate the safety and effectiveness of tau-directed therapies, alone or in combination with the anti-amyloid monoclonal antibody, donanemab, in adults aged 50-80 with late preclinical or early prodromal Alzheimer's disease. …
Phase 2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New pill combo aims to tame type 2 diabetes
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron alone or in combination with dapagliflozin compared with placebo in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone or treated with oth…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Probiotic pill aims to stop recurrent cystitis without antibiotics
Prevention Not yet recruitingRecurrent cystitis is a common condition in menopausal women and is associated with impaired quality of life and increased antibiotic use. This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy and safety of Colipral® in preventing recurren…
Sponsor: Liaquat University of Medical & Health Sciences • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
Free veggies and cooking classes aim to tame diabetes in pregnancy
Disease control Recruiting nowNutrition insecurity (inclusive of food insecurity + poor diet quality) is a fundamental social need that must be addressed to improve treatment and health outcomes for high-risk pregnant women with pregestational type 1 and 2 diabetes, poor glucose control, and food insecurity f…
Sponsor: Ohio State University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Engineered immune cells take aim at debilitating muscle weakness
Disease control Not yet recruitingThis is a Phase I, single-arm, open-label, dose-escalation and dose-expansion study. This is an exploratory clinical study of universal STAR-T cell injection in patients with refractory generalized myasthenia gravis (GMG). Approximately 10-24 participants aged 18-65 years (inclu…
Phase 1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug cocktail aims to boost head and neck cancer surgery success
Disease control Recruiting nowA multicenter, randomized, double-blind, phase II clinical study designed to evaluate the safety, pharmacokinetics, and preliminary efficacy of Becotatug Vedotin for Injection in combination with PD-1 in patients with locally advanced resectable head and neck squamous cell carcin…
Phase 2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New hope for kids with resistant cancers: targeted drug enters trial
Disease control Recruiting nowResearchers are looking for new ways to treat children with relapsed or refractory solid tumors: * Relapsed means the cancer came back after treatment * Refractory means the cancer did not respond (get smaller or go away) to treatment * Solid tumors are cancers mostly in body or…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Brain wave alert: new tool could predict delirium hours before it strikes after heart surgery
Knowledge-focused Not yet recruitingAfter heart surgery, up to half of all patients may develop a state of sudden confusion called postoperative delirium. This condition can lead to longer time on a breathing machine, extended stays in the intensive care unit (ICU), and a slower overall recovery. Currently, doctors…
Sponsor: Southeast University, China • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Can a new 'Nanobody' tracer outsmart standard scans for neuroendocrine cancers?
Diagnosis Not yet recruitingThis study is testing a new PET/CT scan that uses a special tracer called \[⁶⁸Ga\]Ga-DLL3 nanobody to see if it can better detect cancer spread (metastases) in people with neuroendocrine tumors than the standard scans currently used (FDG PET/CT or PSMA PET/CT). DLL3 is a protein …
Phase 2 • Sponsor: Tingting Yuan • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC